Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Aurobindo: US Tariffs “Not A Challenge” For Now, Scouting For Biosimilars Tie-Ups
“Entire” GLP-1 Range Including Semaglutide To Be Launched
Feb 11 2025
•
By
Vibha Ravi
US Tariffs Are Leading To Fears Of Business Disruption
(Shutterstock)
More from India
More from R&D